American Public Education Inc. (APEI) Drops 5.64% on January 11

Equities Staff |

American Public Education Inc. (APEI) was one of the Russell 2000's biggest losers for Monday January 11 as the stock slid 5.64% to $15.72, a loss of $-0.94 per share. Starting at an opening price of $16.92 a share, the stock traded between $15.72 and $16.92 over the course of the trading day. Volume was 105,778 shares over 1,083 trades, against an average daily volume of 117,414 shares and a total float of 16.27 million.

The losses send American Public Education Inc. down to a market cap of $255.71 million. In the last year, American Public Education Inc. has traded between $36.12 and $16.22, and its 50-day SMA is currently $21.11 and 200-day SMA is $24.22.

The stock has a P/E Ratio of 8.2.

American Public Education Inc is a provider of online and on-campus postsecondary education through its two subsidiaries.

American Public Education Inc. is based out of Charles Town, WV and has some 2,250 employees. Its CEO is Wallace E. Boston.

For a complete fundamental analysis analysis of American Public Education Inc., check out’s Stock Valuation Analysis report for APEI. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets

MyForce, Inc.

As parents, we constantly worry about the safety of our loved ones. The media bombards us with incidents from across the nation school shootings, frequent assaults on campuses, and crimes…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…